Genix Pharmaceuticals Company Description
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada.
The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to support kidney health; and Sucanon, a herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults.
It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops.
The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019.
The company was incorporated in 1993 and is based in Vancouver, Canada.
| Country | Canada |
| Founded | 1993 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,000 |
| CEO | Sina Pirooz |
Contact Details
Address: 1055 West Hastings Street Vancouver, Alberta V6E 2E9 Canada | |
| Phone | 604 609 6198 |
| Website | genixpharm.com |
Stock Details
| Ticker Symbol | GENPF |
| Exchange | OTCMKTS |
| Fiscal Year | November - October |
| Reporting Currency | CAD |
| ISIN Number | CA37232A1093 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sina Salehi Pirooz | Chief Executive Officer and Director |
| Mahmoud S. Aziz | Chairman of the Board and President |
| Wayne Kent Lee CA, CPA | Chief Financial Officer |
| Kevin James Bottomley | Director of Corporate Development and Independent Director |
| Monita Franziska Valeska Faris | Company Secretary |